Skip to main content

Table 3 Analysis of baseline factors for HBeAg seroconversion by multivariate cox proportional hazard analysis

From: A model with combined viral and metabolic factors effectively predicts HBeAg status under long term entecavir therapy: a prospective cohort study

Baseline characteristics

Univariate

Multivariate

 

P

Odd ritio

95 % CI

P

Age, yr

0.438

   

Gender (male/female)

0.896

   

BMI (≥24 kg/m2)

<0.001

0.4

0.2–0.8

0.013

Baseline ALT (IU/L)

   

0.004

ALT < 80

0.003

1

1

 

80 ≤ ALT < 200

0.995

1.1

0.6–2.0

0.83

ALT ≥ 200

0.002

2.5

1.3–4.8

0.005

Baseline HBV DNA(log10copies/ml)

   

<0.01

HBV DAN < 7

<0.001

1

1

 

7 ≤ HBV DNA < 9

<0.001

2.8

1.4–5.6

0.003

HBV DNA ≥ 9

<0.001

0.8

0.3–2.0

0.773

Time of undetectable HBV DNA

   

<0.01

≤24 weeks

<0.001

3.2

1.9–5.5

<0.001

24 < HBV DNA ≤ 48 weeks

<0.001

1.3

0.6–2.9

0.485

>48 weeks

0.385

1

1

 

Time of Normalization ALT

    

≤12 weeks

0.346

   

12 < ALT ≤ 24 weeks

0.018

   

>24 weeks

0.007

1

1

Â